Treatment of GuillainBarre syndrome a costeffectiveness analysis Nagpal S, Benstead T, Shumak K, Rock G, Brown M, Anderson D R Record Status This is aThe increasing adoption of highcost IVIG products and growing awareness among patient population leading to higher diagnosis rate in developed and emerging countries Gupta A, Taly AB, Srivastava A, Murali T GuillainBarre Syndrome – rehabilitation outcome, residual deficits and requirement of lower limb orthosis for locomotion at
Guillain Barre Syndrome Surveillance And Cost Of Treatment Strategies Authors Reply The Lancet
